BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27279572)

  • 1. Nanoparticles-cell association predicted by protein corona fingerprints.
    Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
    Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.
    Liu R; Jiang W; Walkey CD; Chan WC; Cohen Y
    Nanoscale; 2015 Jun; 7(21):9664-75. PubMed ID: 25959034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints.
    Afantitis A; Melagraki G; Tsoumanis A; Valsami-Jones E; Lynch I
    Nanotoxicology; 2018 Dec; 12(10):1148-1165. PubMed ID: 30182778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
    Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
    Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
    Kharazian B; Hadipour NL; Ejtehadi MR
    Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional dissection of the plasma corona of SiO₂-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages.
    Fedeli C; Segat D; Tavano R; Bubacco L; De Franceschi G; de Laureto PP; Lubian E; Selvestrel F; Mancin F; Papini E
    Nanoscale; 2015 Nov; 7(42):17710-28. PubMed ID: 26451907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein corona and nanoparticles: how can we investigate on?
    Pederzoli F; Tosi G; Vandelli MA; Belletti D; Forni F; Ruozi B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles.
    Nguyen VH; Meghani NM; Amin HH; Tran TTD; Tran PHL; Park C; Lee BJ
    Colloids Surf B Biointerfaces; 2018 Oct; 170():179-186. PubMed ID: 29906703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
    Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
    ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles.
    Vitali M; Rigamonti V; Natalello A; Colzani B; Avvakumova S; Brocca S; Santambrogio C; Narkiewicz J; Legname G; Colombo M; Prosperi D; Grandori R
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1556-1564. PubMed ID: 29621630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant titration of nanoparticle-protein corona.
    Maiolo D; Bergese P; Mahon E; Dawson KA; Monopoli MP
    Anal Chem; 2014 Dec; 86(24):12055-63. PubMed ID: 25350777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
    Wang H; Lin Y; Nienhaus K; Nienhaus GU
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches.
    Papa E; Doucet JP; Sangion A; Doucet-Panaye A
    SAR QSAR Environ Res; 2016 Jul; 27(7):521-38. PubMed ID: 27329717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A health concern regarding the protein corona, aggregation and disaggregation.
    Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.